跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HEMANGIOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HEMANGIOL
Authorized
STANDARD
HEMANGIOL
pierre fabre dermo-cosmetique canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e252acbe7a4ff2e0
Company
pierre fabre dermo-cosmetique canada inc
Type
Standard
Approval Details
Approval Id
e252acbe7a4ff2e0
Drug Approval Canada Name
HEMANGIOL
Product Name
HEMANGIOL
Status
Marketed
Status Date
2017-03-23
Original Market Date
2017-03-23
Din
02457857
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AA05 PROPRANOLOL
Atc Name
c 07 aa 05
Aig Number
0159470001
Company Name
pierre fabre dermo-cosmetique canada inc
Company Address
115, 9955 Rue De Chateauneuf, Brossard, Quebec, Canada, J4Z 3V5
Active Ingredients
PROPRANOLOL (PROPRANOLOL HYDROCHLORIDE)
3.75 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e252acbe7a4ff2e0
Type
Standard
Back to Health Canada Approvals